Dr Reddy launches 'Supanac' tablets

Subscribe to Oneindia News

Hyderabad, Jan 16 (UNI) Dr Reddy's Laboratories has launched Supanac (Diclofenac Potassium 50 mg) tablets in India, increasing its offering in the Rs 2,700 crore Non-Steroidal Anti-Inflammatory Drug (NSAID) market.

The drug, with analgesic, anti-pyretic and anti-inflammatory properties licensed from Applied Pharma Research (APR) of Switzerland, is used for acute pain management, a release here said.

This patented product was developed by Dynamic Buffered Technology (DBT).

UNI VA DS GM 1806

Please Wait while comments are loading...